SEARCH BY
| Category | Company |
|---|---|
| Founded | 1981 |
| Sector | Medical Products |
| Employees | 1,725 |
| Revenue | 1.0B USD (2022) |
Abiomed is a cardiovascular device company. Abiomed develops, manufactures, and markets medical products designed to establish recovery's as the standard of care for acute patients. Abiomed was formed in 1981 and is based in Danvers, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Medical Products M&A | 4 of 4 |
| Type: Add-on Acquisition M&A Deals | 4 of 4 |
| State: Minnesota M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-04-29 |
Breethe
Longueuil, Quebec, Canada Breethe, Inc. is a developer of a novel extracorporeal membrane oxygenation (ECMO) system that will complement and expand Abiomed’s product portfolio to more comprehensively serve the needs of patients whose lungs can no longer provide sufficient oxygenation, including patients suffering from cardiogenic shock or respiratory failures such as due to ARDS, H1N1, SARS, or COVID-19. ECMO has also been utilized as a primary method of oxygenation and hemodynamic support for pediatric patients. Breethe was founded in 2014 and is based in Longueuil, Quebec. |
Buy | - |
